Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AGE

AgeX Therapeutics (AGE)

AgeX Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AGE
DateTimeSourceHeadlineSymbolCompany
03/22/20245:27PMGlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
03/07/20244:49PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
03/07/20244:47PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
03/07/20247:47AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
02/14/20244:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
02/14/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
02/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
02/05/20247:19AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
01/18/20245:29PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
01/17/20244:19PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/16/20249:11AMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/11/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
01/09/20244:16PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
01/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/28/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/18/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/13/20235:11PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
12/08/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
12/01/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/17/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/16/20234:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
11/15/20239:38AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
11/14/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/14/20234:05PMBusiness WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
11/07/20234:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
11/07/20234:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
11/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
11/01/20234:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
10/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:AGE